Virtu Financial’s Quest Diagnostics DGX Stock Holding History

Virtu Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,038	Closed	-$527K	–	1764
2025 Q4	$527K	Buy	+3,038	New	+$553K	0.02%	580
2025 Q2	–	Sell	-4,503	Closed	-$762K	–	1587
2025 Q1	$762K	Buy	4,503 +1,990	+79%	+$327K	0.04%	368
2024 Q4	$379K	Buy	+2,513	New	+$391K	0.02%	600
2024 Q3	–	Sell	-5,745	Closed	-$786K	–	1479
2024 Q2	$786K	Buy	+5,745	New	+$787K	0.05%	340
2023 Q4	–	Sell	-3,076	Closed	-$375K	–	1655
2023 Q3	$375K	Buy	+3,076	New	+$410K	0.04%	422
2023 Q1	–	Sell	-4,404	Closed	-$689K	–	1631
2022 Q4	$689K	Buy	+4,404	New	+$633K	0.09%	205
2022 Q2	–	Sell	-3,380	Closed	-$463K	–	1676
2022 Q1	$463K	Buy	+3,380	New	+$471K	0.03%	419
2021 Q4	–	Sell	-3,726	Closed	-$541K	–	1808
2021 Q3	$541K	Buy	+3,726	New	+$545K	0.05%	430
2017 Q4	–	Sell	-29,203	Closed	-$2.73M	–	2459
2017 Q3	$2.73M	Buy	+29,203	New	+$3.1M	0.14%	107

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Virtu Financial's DGX Position: Q1 2026 in Review

Virtu Financial sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 3,038 shares — an estimated $527K sold.

Virtu Financial first reported a position in DGX in Q3 2017 and held it in 9 quarters. The position peaked at $2.73M in Q3 2017. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Virtu Financial reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 3,038 Quest Diagnostics shares in Q1 2026, an estimated $527K.
Virtu Financial first reported a position in Quest Diagnostics in Q3 2017 and held it in 9 quarters.
Virtu Financial's Quest Diagnostics position peaked at $2.73M in Q3 2017.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.